Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Intravenous (IV) Iron and Oral Iron Market – Strategic Assessment and Forecast Till 2021

Thursday, February 16, 2017 0:43
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Bigmarketresearch.com include new market research report “Global Intravenous (IV) Iron and Oral Iron Market” Attractiveness, Competitive Landscape and Forecasts” to its huge collection of research reports

Request sample copy: http://www.bigmarketresearch.com/request-sample/909601

Global intravenous (IV) iron and oral iron market is expected to cross US$ 3 billion by 2021, growing at a CAGR of 5%.
Iron drugs are the supplements containing iron prescribed by a doctor to treat anemia or other iron deficiencies. Oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body and intravenous (IV) iron therapy comes into the picture.

Enquire about report @ http://www.bigmarketresearch.com/report-enquiry/909601

Global Intravenous (IV) Iron and Oral Iron Market – Market Size and Dynamics
Analysts at Beige Market Intelligence expects the global intravenous (IV) iron and oral iron market to cross US$ 3 billion by 2021, growing at an impressive CAGR close to 5%. Iron drugs are widely used in various therapeutic areas like nephrology, gynaecology, oncology, gastroenterology, surgeries, and chronic heart failures. This catalyses the growth of global intravenous (IV) iron and oral iron market. Furthermore, factors such as correction of IDA in pregnancy, growing diabetic population worldwide, growing incidence of Chronic Kidney Disease (CKD) that increases the need of dialysis, prevalence of iron deficiency are the major factors attributing to the growth of the market.

Browse full report @ http://www.bigmarketresearch.com/global-intravenous-iv-iron-and-oral-iron-strategic-assessment-and-forecast-till-2021-market

Intravenously iron is delivered to patients who are either unable to absorb oral iron or who has increasing anemia despite adequate doses of oral iron. Growing incidence of Chronic Kidney Disease (CKD), iron deficiency diseases related to gynecology, nephrology, gastroenterology, and oncology is driving growth of the intravenous iron therapy. The high growth rate of IV iron market can be attributed to the paradigm shift of healthcare providers/patients to IV iron therapies from oral iron therapies.
The research report provides a detailed analysis and growth forecast of each therapeutic area. Nephrology is the largest application area of the intravenous (IV) iron and oral iron drugs followed by Gynecology and Gastroenterology.

About Big Market Research:

Big Market Research uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim.

Our strength is in our research analysts who with their proactive approach can source best and correct information which can be detrimental in organizations success. We follow six sigma standards leaving no scope for error.

Contact Big Market Research:

Direct Contact: + 1-503-894-6022
Toll Free: + 1-800-910-6452
Email: help@bigmarketresearch.com
Web: http://www.bigmarketresearch.com
 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.